| | 330942-05-7 Basic information More.. |
| Product Name: | Betrixaban | | Synonyms: | Betrixaban;N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide;Betrixaban, >=98%;Betrixaban, PRT-054021;1-C-{4-[aMino(diMethylaMino)Methyl]benzene}-2-N-(5-chloropyridin-2-yl)-4-Methoxybenzene-1,2-dicarboxaMide;N-(5-Chloro-2-pyridinyl)-2-[[4-[(diMethylaMino)iMinoMethyl]benzoyl]aMino]-5-MethoxybenzaMide;PRT 054021;N-(5-chloropyridin-2-yl)-2-(4-(N,N-diMethylcarbaMiMidoyl)benzaMido)-4-MethoxybenzaMide | | CAS: | 330942-05-7 | | MF: | C23H22ClN5O3 | | MW: | 451.91 | | EINECS: | 682-459-2 | | Mol File: | 330942-05-7.mol |  |
Use
Betrixaban is a novel anticoagulant, an oral direct inhibitor of factor Xa (FXa) for use in the prevention of venous thromboembolism (VTE).
- Betrixaban
-
- US $0.00 / g
- 2025-08-13
- CAS:330942-05-7
- Min. Order: 1g
- Purity: 98%min
- Supply Ability: 1000g
- Betrixaban
-
- US $39.00-97.00 / mg
- 2025-07-14
- CAS:330942-05-7
- Min. Order:
- Purity: 99.35%
- Supply Ability: 10g
- Betrixaban
-
- US $50.00 / kg
- 2023-09-11
- CAS:330942-05-7
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10000tons
|
|
330942-05-7
Recommend Suppliers |
|